A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...

While the tariff cut was welcomed widely, the unequal structure of the agreement has raised a fundamental question: Is India celebrating a strategic win, or accepting an uneven trade compromise? Check ...

EMA committee recommends conditional marketing authorization to Sanofi’s Rezurock to treat chronic graft-vs-host disease: Paris Monday, February 2, 2026, 10:00 Hrs [IST] Sanofi ...

Just 7% of HFrEF patients received quadruple therapy, and even in this group, the absolute risk of events at 1 year was high.

Rezurock is approved in 20 countries, including the US, UK, and Canada for the treatment of patients 12 years and older with chronic GVHD after failure of at least two prior lines of systemic therapy ...

ICG Silver & Gold Ltd. ("ICG" or the "Company") is pleased to announce its intention to complete a Subscription Receipt ...

MIT's Project NANDA reported in July 2025 that around 95% of enterprise GenAI pilots failed to deliver measurable value. The report stated that most failures resulted from misaligned tasks or poor ...